| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. (APLS) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. APLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.18M | $48.30M | - | |
| CEO | 482.0K | $19.78M | - | |
| Dir | 385.0K | $15.80M | - | |
| Dir | 161.6K | $6.63M | - | |
| CFO | 152.0K | $6.24M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2021 | Grossi Federico53 | Chief Medical Officer | Sell | 500 | $46.00 | $23,000.00 | -0.8% | +18.6% | +4.0% | |
| Feb 16, 2021 | MacHiels Alec57 | Director | Sale+OE | 2,500 | $46.00 | $115,000.00 | -0.4% | +18.6% | +4.0% | |
| Feb 9, 2021 | Perry Nicole D69 | Vice President - Accounting | Sale+OE | 2,000 | $50.00 | $100,000.00 | -44.4% | -8.5% | -1.9% | |
| Feb 1, 2021 | Grossi Federico53 | Chief Medical Officer | Sell | 600 | $44.00 | $26,400.00 | -1.0% | - | - | |
| Jan 15, 2021 | MacHiels Alec57 | Director | Sale+OE | 2,500 | $53.15 | $132,875.00 | -0.4% | - | - | |
| Jan 14, 2021 | Grossi Federico53 | Chief Medical Officer | Sell | 4,000 | $51.99 | $207,960.00 | -10.0% | - | - | |
| Jan 4, 2021 | Grossi Federico53 | Chief Medical Officer | Sell | 600 | $57.24 | $34,344.00 | -1.5% | - | - | |
| Jan 4, 2021 | Perry Nicole D69 | Vice President - Accounting | Sale+OE | 2,000 | $57.24 | $114,480.00 | -100% | - | - | |
| Dec 15, 2020 | MacHiels Alec57 | Director | Sale+OE | 2,500 | $52.16 | $130,400.00 | -0.4% | - | - | |
| Dec 15, 2020 | Francois Cedric78 | Chief Executive Officer | Sell | 5,000 | $52.16 | $260,800.00 | -0.4% | - | - |